1. Efficacy of dupilumab for controlling severe atopic dermatitis with dominant‐negative CARD11 variant. (1st October 2021) Authors: Charvet, E.; Bourrat, E.; Hickman, G.; Donadieu, J.; Bellanné‐Chantelot, C.; Jachiet, M.; Bouaziz, J‐D.; Bagot, M.; Cassius, C. Journal: Clinical and experimental dermatology Issue: Volume 46:Number 7(2021) Page Start: 1334 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Efficacy of dupilumab for controlling severe atopic dermatitis with dominant‐negative CARD11 variant. (2nd June 2021) Authors: Charvet, E.; Bourrat, E.; Hickman, G.; Donadieu, J.; Bellanné‐Chantelot, C.; Jachiet, M.; Bouaziz, J‐D.; Bagot, M.; Cassius, C. Journal: Clinical and experimental dermatology Issue: Volume 46:Number 7(2021) Page Start: 1334 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Second primary cutaneous melanoma in patients with advanced melanoma treated with anti‐programmed‐death‐receptor‐1 monoclonal antibodies. (1st April 2021) Authors: Charvet, E.; Kramkimel, N.; Chaplain, L.; Gantzer, A.; Kassem, O.; Longvert, C.; Blom, A.; Dupin, N.; Aractingi, S.; Hamon, M.; Zimmermann, U.; Emile, J.‐F.; Sohier, P.; Sidibé, T.; Saiag, P.; Funck‐Brentano, E. Journal: British journal of dermatology Issue: Volume 184:Number 4(2021) Page Start: 746 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Second primary cutaneous melanoma in patients with advanced melanoma treated with anti‐programmed‐death‐receptor‐1 monoclonal antibodies. (1st December 2020) Authors: Charvet, E.; Kramkimel, N.; Chaplain, L.; Gantzer, A.; Kassem, O.; Longvert, C.; Blom, A.; Dupin, N.; Aractingi, S.; Hamon, M.; Zimmermann, U.; Emile, J.‐F.; Sohier, P.; Sidibé, T.; Saiag, P.; Funck‐Brentano, E. Journal: British journal of dermatology Issue: Volume 184:Number 4(2021) Page Start: 746 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗